| Record ID | talis_openlibrary_contribution/talis-openlibrary-contribution.mrc:1365843875:874 |
| Source | Talis |
| Download Link | /show-records/talis_openlibrary_contribution/talis-openlibrary-contribution.mrc:1365843875:874?format=raw |
LEADER: 00874cam a2200241 a 4500
001 3791c700375b4d12b91a2ffbe718abe6
003 UK-BiTAL
005 20050705143357.0
008 971010s1997 enkc 100 ||eng|d
015 $aGB9766472$2bnb
020 $a1853153354
035 $a()1853153354
040 $dUK-BiTAL
082 04 $a616.135$221
245 00 $aHRT and thromboembolism /$cedited by David Sturdee.
260 $a[London] :$bRoyal Society of Medicine Press for the British Menopause Society,$cc1997.
300 $a40p. :$bports. ;$c24 cm.
440 0 $aRound table series ;$v50
500 $a"Proceedings of a Round table discussion held at the Royal Society of Medicine, London, on 14 April 1997".
650 0 $aMenopause$xHormone therapy$xCongresses.
650 0 $aThromboembolism$xCongresses.
700 1 $aSturdee, David William.
710 2 $aBritish Menopause Society.